Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex

Epilepsy Res. 2005 Oct-Nov;67(1-2):51-60. doi: 10.1016/j.eplepsyres.2005.08.006. Epub 2005 Sep 26.

Abstract

We investigated the effect of Zonisamide (ZNS), a newer anti-epileptic drug, on field potentials and neuropropagation in rat frontal cortex, with the aid of the 64-channel multi-electrode dish (MED64) system. The amplitude and propagation of field potentials were expressed dimensionally in the MED64 system. ZNS (3-100 microM) inhibited the amplitude and propagation of field excitatory postsynaptic potentials (fEPSP) in a concentration dependent manner. In contrast, ZNS could not suppress the amplitude and propagation of the presynaptic fiber volley (PrV) at clinically relevant concentrations (10-30 microM). Stimulating dependency with reduction fEPSP was seen in the presence of ZNS at clinically relevant concentrations, but not with PrV. The reduction of fEPSP amplitude was not accompanied by a change in paired-pulse facilitation. These data suggest that at clinically relevant concentrations of ZNS, the suppression of neuronal propagation is at least partially due to the postsynaptic mechanism, probably through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Anticonvulsants / pharmacology*
  • Dose-Response Relationship, Drug
  • Electrodes, Implanted
  • Excitatory Postsynaptic Potentials / drug effects*
  • Frontal Lobe / drug effects*
  • Frontal Lobe / physiology
  • Isoxazoles / pharmacology*
  • Male
  • Phenytoin / pharmacology
  • Presynaptic Terminals / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Zonisamide

Substances

  • Anticonvulsants
  • Isoxazoles
  • Zonisamide
  • Phenytoin